The Cancer of the Pancreas Screening-5 (CAPS5) Study

What is the purpose of this trial?

The purpose of the study is to evaluate pancreatic fluid mutations and circulating pancreatic epithelial cells as accurate markers of neoplasia by comparing their prevalence in cases with sporadic pancreatic neoplasia to healthy and disease controls; to compare the prevalence of pancreatic fluid mutations and circulating pancreatic epithelial cells among a prospective cohort of individuals with sporadic pancreatic cysts undergoing pancreatic surveillance.


Participation Guidelines

Ages: 18 years and older

Gender: Both


American Association for Cancer Research

Start Date: 05/12/2015

End Date: 10/31/2021

Last Updated: 06/22/2018

Study HIC#: 1408014448

Get Involved

For more information about this study, contact:
James Farrell
+1 203-785-4796
james.j.farrell@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

James Farrell

Principal Investigator

Sub-Investigators